ARS Pharmaceuticals Inc — 四半期キャッシュフロー (NASDAQ:SPRY) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 351.15 M327.32 M313.47 M372.8 M327.65 M 負債合計 94.36 M98.34 M121.15 M225.15 M213.39 M 純資産合計 256.8 M228.97 M192.32 M147.66 M114.26 M 負債および純資産合計 351.15 M327.32 M313.47 M372.8 M327.65 M 有利子負債合計 ———97.76 M96.37 M 純負債 ———-190.45 M-148.61 M

ニュース

ARS Pharmaceuticals: Neffy's Slow Launch, No Guidance For 2026 Keep Me On Sidelines (SPRY)

Leerink、販売拡大を受けてARS Pharmaceuticals株の目標株価を引き上げ

Leerink raises ARS Pharmaceuticals stock price target on sales expansion

ARS Pharmaceuticals、2025年第4四半期予想を上回り株価上昇

Earnings call transcript: ARS Pharmaceuticals beats Q4 2025 forecasts, stock rises

ARS Pharmaceuticals, Inc. (SPRY) Q4 2025 Earnings Call Transcript

【決算速報】ARS Pharmaceuticals、売上高は予想を上回り、利益は予想を上回る結果に

ARS Pharmaceuticals earnings beat by $0.01, revenue topped estimates

ARS Pharmaceuticals, Inc. (SPRY) Reports Q4 Loss, Beats Revenue Estimates

Canadian Natural to Report Q4 Earnings: What's in the Offing?

ARS Pharmaceuticals, Inc. (SPRY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Raymond James、ARS Pharmaceuticals株にStrong Buy評価を継続